Maryland-based business protecting individuals and businesses from environmental hazards through the use of its innovative sensor technology COLUMBIA, Md. (May…
ROCKVILLE, Md., May 16, 2023 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that preclinical research in Mucopolysaccharidosis type IVA…
Analysis of international public-sector contributions to Food and Drug Administration (FDA)-approved drugs and vaccines allows for a more thorough examination…